Axxam is a contract research and discovery company. Its capabilities and expertise include molecular biology (cloning, gene expression analysis, protein expression, genomic engineering), assay development and reagent provision (cellular and biochemical systems), as well as compound management. The company also specializes in fully automated high-throughput screening, hit characterization and profiling, cardiac safety and liability profiling, and electrophysiology.